Prot #LP0133-1275: Phase 2b Dose-Ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-Week Treatment Period in Adult Subjects with Atopic Dermatitis
- Liszewski, Walter Joseph (PD/PI)
- Silverberg, Jonathan I (Other)
Project: Research project